Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines
- PMID: 20428086
- PMCID: PMC6257326
- DOI: 10.3390/molecules15042886
Pharmacogenomic identification of c-Myc/Max-regulated genes associated with cytotoxicity of artesunate towards human colon, ovarian and lung cancer cell lines
Abstract
Development of novel therapy strategies is one of the major pressing topics of clinical oncology to overcome drug resistance of tumors. Artesunate (ART) is an anti-malarial drug, which also exerts profound cytotoxic activity towards cancer cells. We applied a gene-hunting approach using microarray-based transcriptome-wide mRNA expression profiling and COMPARE analyses. We identified a set of genes, whose expression was associated either with high IC50 values or low IC50 values for ART. Therefore, these genes may function as resistance or sensitivity factors for response of tumor cells towards ART. This viewpoint is conceivable for genes involved in ribosomal activity, drug transport, cellular antioxidant defense, apoptosis, cell proliferation, cell cycle progression etc. An investigation of underlying signal transduction by pathway analysis suggested a role of the signaling pathways related to tumor necrosis factor (TNF) and the tumor suppressor p53. On the other hand, there were genes without obvious functional link to cellular response to ART, such as genes involved in the survival of cochlear outer and inner hair cells etc. We proved the hypothesis that ART influences the activity of transcription factors regulating downstream genes involved or not involved in response of cancer cells towards ART. This would explain the identification of genes with and without obvious relation to the cytotoxic activity of ART by microarray and COMPARE analyses. By analysis of the binding motifs for the transcription factors c-Myc and Max, we indeed found that 53 of 56 genes contained one or more binding sites for c-Myc/Max upstream of the gene-location. We conclude that c-Myc and Max-mediated transcriptional control of gene expression might contribute to the therapeutic effects of ART in cancer cells, but may also confer unwanted side effects by affecting therapy-unrelated genes.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures



Similar articles
-
Factors determining sensitivity or resistance of tumor cell lines towards artesunate.Chem Biol Interact. 2010 Apr 15;185(1):42-52. doi: 10.1016/j.cbi.2010.02.002. Epub 2010 Feb 6. Chem Biol Interact. 2010. PMID: 20144594
-
MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex.Proc Natl Acad Sci U S A. 2021 Sep 14;118(37):e2024824118. doi: 10.1073/pnas.2024824118. Proc Natl Acad Sci U S A. 2021. PMID: 34493659 Free PMC article.
-
Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.Oncotarget. 2015 Oct 13;6(31):31569-92. doi: 10.18632/oncotarget.5035. Oncotarget. 2015. PMID: 26427040 Free PMC article.
-
The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.Cold Spring Harb Symp Quant Biol. 1994;59:109-16. doi: 10.1101/sqb.1994.059.01.014. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587059 Review.
-
Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases.World J Gastroenterol. 2016 Sep 21;22(35):7938-50. doi: 10.3748/wjg.v22.i35.7938. World J Gastroenterol. 2016. PMID: 27672289 Free PMC article. Review.
Cited by
-
Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells.J Transl Med. 2014 Aug 21;12:226. doi: 10.1186/s12967-014-0226-x. J Transl Med. 2014. PMID: 25143136 Free PMC article.
-
Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2.Onco Targets Ther. 2015 Apr 16;8:845-54. doi: 10.2147/OTT.S81041. eCollection 2015. Onco Targets Ther. 2015. PMID: 25945055 Free PMC article.
-
Artesunate shows potent anti-tumor activity in B-cell lymphoma.J Hematol Oncol. 2018 Feb 20;11(1):23. doi: 10.1186/s13045-018-0561-0. J Hematol Oncol. 2018. PMID: 29458389 Free PMC article.
-
Biomarker Expression Profiling in Cervix Carcinoma Biopsies Unravels WT1 as a Target of Artesunate.Cancer Genomics Proteomics. 2022 Nov-Dec;19(6):727-739. doi: 10.21873/cgp.20355. Cancer Genomics Proteomics. 2022. PMID: 36316038 Free PMC article.
-
Transcriptome meta-analysis reveals a dysregulation in extra cellular matrix and cell junction associated gene signatures during Dengue virus infection.Sci Rep. 2016 Sep 21;6:33752. doi: 10.1038/srep33752. Sci Rep. 2016. PMID: 27651116 Free PMC article. Review.
References
-
- Klayman D.L. Qinghaosu (artemisinin): An antimalarial drug from China. Science. 1985;228:1049–1055. - PubMed
-
- Tu Y. The development of new antimalarial drugs: Qinghaosu and dihydro-qinghaosu. Chin. Med. J. (Engl.) 1999;112:976–977. - PubMed
-
- Li Y., Wu Y.L. How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives? Med. Trop. (Mars) 1998;58:9–12. - PubMed
-
- Efferth T., Fu Y.J., Zu Y.G., Schwarz G., Konkimalla V.S., Wink M. Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine. Curr. Med. Chem. 2007;14:2024–2032. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous